×
About 476 results

ALLMedicine™ Gynecologic Oncology Center

Research & Reviews  167 results

The impact of expanding gynecologic oncology care to ovarian cancer patients in small c...
https://doi.org/10.1016/j.ygyno.2021.04.021
Gynecologic Oncology; Swayze EJ, Strzyzewski L et. al.

Apr 23rd, 2021 - Patients with ovarian cancer from smaller cities and rural communities face unique challenges in accessing comprehensive care. This study compares management strategies, outcomes, and access to care for patients in a small city and surrounding rur...

The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039172
Journal of Gynecologic Oncology; Ikeda M, Shida M et. al.

Apr 7th, 2021 - The Japan Society of Gynecologic Oncology published the first guidelines for the treatment of cervical cancer in 2007. The aim of this research was to evaluate the influence of the introduction of the first guideline on clinical trends and outcome...

Impact of cytoreductive surgery on survival of patients with low-grade serous ovarian c...
https://doi.org/10.1002/jso.26450
Journal of Surgical Oncology; Vatansever D, Taskiran C et. al.

Mar 3rd, 2021 - The aim of this study was to analyze the factors affecting recurrence-free (RFS) and overall survival (OS) rates of women diagnosed with low-grade serous ovarian cancer (LGSOC). Databases from 13 participating centers in Turkey were searched retro...

Outcomes of enhanced recovery after surgery (ERAS) in gynecologic oncology - A systemat...
https://doi.org/10.1016/j.ygyno.2020.12.035
Gynecologic Oncology; Bisch SP, Jago CA et. al.

Jan 3rd, 2021 - To assess the benefit of Enhanced Recovery After Surgery (ERAS) on length of stay (LOS), postoperative complications, 30-day readmission, and cost in gynecologic oncology. A systematic literature search was performed in MEDLINE, EMBASE, Cochrane R...

Discrepancies between author- and industry-reported disclosures of financial relationsh...
https://doi.org/10.1016/j.ygyno.2020.10.039
Gynecologic Oncology; Guo XM, Cowan M et. al.

Nov 14th, 2020 - Trillions of dollars pass to physicians from industry-related businesses annually, leading to many opportunities for financial conflicts of interest. The Open Payments Database (OPD) was created to ensure transparency. We describe the industry rel...

see more →

Guidelines  17 results

Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement
https://www.gynecologiconcology-online.net/article/S0090-8258(19)31805-0/fulltext
Gynecology Oncology; Whitcomb B,et al

Jan 12th, 2020 - Providers should focus indications, alternatives, risks and benefits of medical cannabis use to make appropriate referrals.

Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cerv...
https://doi.org/10.1007/s10147-018-1351-y
International Journal of Clinical Oncology; Ebina Y, Mikami M et. al.

Oct 6th, 2018 - The Japan Society of Gynecologic Oncology (JSGO) Guidelines 2017 for the Treatment of Uterine Cervical Cancer are for the purpose of providing standard treatment strategies for cervical cancer, indicating treatment methods currently considered app...

Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gyne...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981107
Journal of Gynecologic Oncology; Suh DH, Chang SJ et. al.

May 17th, 2018 - Since after 2006 when the first edition of practice guidelines for gynecologic oncologic cancer treatment was released, the Korean Society of Gynecologic Oncology (KSGO) has published the following editions on a regular basis to suggest the best p...

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cance...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882649
International Journal of Clinical Oncology; Saito T, Tabata T et. al.

Nov 21st, 2017 - Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO) guidelines...

Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gyn...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391389
Journal of Gynecologic Oncology; Lim MC, Lee M et. al.

Apr 6th, 2017 - Clinical practice guidelines for gynecologic cancers have been developed by academic society from several countries. Each guideline reflected their own insurance system and unique medical environment, based on the published evidence. The Korean So...

see more →

Clinicaltrials.gov  263 results

Hormonal Intrauterine Device Under Study for Managing Early Endometrial Cancer
https://ascopost.com/issues/may-10-2021/hormonal-intrauterine-device-under-study-for-managing-early-endometrial-cancer/

May 9th, 2021 - Disease regression was observed in 82% of women with endometrial hyperplasia with atypia and 43% of women with endometrial cancer after treatment for 6 months with a hormonal intrauterine device in a phase II study reported during the virtual edit...

5-Year Follow-up of SOLO-1: Sustained Benefit for Maintenance Olaparib in Ovarian Cancer
https://ascopost.com/issues/april-25-2021/sustained-benefit-for-maintenance-olaparib-in-ovarian-cancer/

Apr 24th, 2021 - In the 5-year follow-up of the pivotal SOLO-1 trial in women with newly diagnosed advanced ovarian cancer and a BRCA1/2 mutation, maintenance treatment with olaparib led to a more than doubling in progression-free survival, according to a presenta...

The impact of expanding gynecologic oncology care to ovarian cancer patients in small c...
https://doi.org/10.1016/j.ygyno.2021.04.021
Gynecologic Oncology; Swayze EJ, Strzyzewski L et. al.

Apr 23rd, 2021 - Patients with ovarian cancer from smaller cities and rural communities face unique challenges in accessing comprehensive care. This study compares management strategies, outcomes, and access to care for patients in a small city and surrounding rur...

The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039172
Journal of Gynecologic Oncology; Ikeda M, Shida M et. al.

Apr 7th, 2021 - The Japan Society of Gynecologic Oncology published the first guidelines for the treatment of cervical cancer in 2007. The aim of this research was to evaluate the influence of the introduction of the first guideline on clinical trends and outcome...

SGO and FWC Issue Joint Statement on the Elimination of HPV
https://ascopost.com/issues/march-25-2021/sgo-and-fwc-issue-joint-statement-on-the-elimination-of-hpv/

Mar 24th, 2021 - United in their commitment to eliminate human papillomavirus (HPV)-related cancer, the Society of Gynecologic Oncology (SGO) and the Foundation for Women’s Cancer (FWC) recently endorsed a series of vaccine recommendations. HPV vaccines are among ...

see more →

News  29 results

Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement
https://www.gynecologiconcology-online.net/article/S0090-8258(19)31805-0/fulltext
Gynecology Oncology; Whitcomb B,et al

Jan 12th, 2020 - Providers should focus indications, alternatives, risks and benefits of medical cannabis use to make appropriate referrals.

New leaders at SGO, AACR
https://www.mdedge.com/hematology-oncology/article/198339/business-medicine/new-leaders-sgo-aacr?channel=59288
Jennifer Smith

Apr 5th, 2019 - The Society of Gynecologic Oncology (SGO) has a new leader at the helm. Dr.

Surgery to Reduce Ovarian Cancer Risk — One Step or Two?
https://www.staging.medscape.com/viewarticle/910898

Mar 24th, 2019 - HONOLULU — High-risk women who undergo prophylactic surgery to reduce ovarian cancer risk have few lingering worries about developing cancer in the future or regrets about their decision to undergo that surgery, suggest results from two studies. T...

Surgery to Reduce Ovarian Cancer Risk — One Step or Two?
https://www.medscape.com/viewarticle/910898

Mar 24th, 2019 - HONOLULU — High-risk women who undergo prophylactic surgery to reduce ovarian cancer risk have few lingering worries about developing cancer in the future or regrets about their decision to undergo that surgery, suggest results from two studies. T...

TWiST Strengthens PARP Inhibitor Role in Ovarian Cancer
https://www.medscape.com/viewarticle/910546

Mar 17th, 2019 - HONOLULU — A new analysis of the phase 3 NOVA trial strengthens earlier findings that niraparib (Zejula, Tesaro) provides meaningful clinical benefit for patients with platinum-sensitive, recurrent ovarian cancer compared with placebo by prolongin...

see more →